Pharmaron Beijing Co., Ltd. Class H (17Q1) Stock Forecast & Price Target
17Q1 Analyst Ratings
Strong Buy
4Buy1Hold0Sell
Based on 5 analysts giving stock ratings to Pharmaron Beijing Co., Ltd. Class H in the past 3 months
17Q1 Stock 12 Month Forecast
Average Price Target
EUR 4.88▲(58.47% Upside)Based on 5 Wall Street analysts offering 12 month price targets for Pharmaron Beijing Co., Ltd. Class H in the last 3 months. The average price target is EUR 4.88 with a high forecast of EUR 7.08 and a low forecast of EUR 3.79. The average price target represents a 58.47% change from the last price of EUR 3.08.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 7.08
AverageEUR 4.88
LowEUR 3.79
Highest Price TargetHighestEUR 7.08Average Price TargetEUR 4.88Lowest Price TargetLowestEUR 3.79
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Morgan Stanley | EUR 4.17 | buy | 35.40%Upside | Reiterated | 09/16/26 | ||
| Chen Chen | UBS | EUR 3.63→EUR 4.03 | hold | 30.94%Upside | Downgraded | 08/25/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | EUR 5.32 | buy | 72.86%Upside | Reiterated | 08/25/26 | ||
| Unknown AnalystNot Ranked | Citi | EUR 5.14→EUR 7.08 | buy | 129.99%Upside | Reiterated | 08/24/26 | ||
| Unknown AnalystNot Ranked | Goldman Sachs | EUR 3.34→EUR 3.79 | buy | 23.15%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | Nomura | EUR 3.68 | buy | 19.45%Upside | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | HSBC | EUR 3.52 | buy | 14.25%Upside | Reiterated | 07/15/26 | ||
| Unknown AnalystNot Ranked | Daiwa | EUR 2.91 | buy | -5.41%Downside | Reiterated | 07/14/26 | ||
| Unknown AnalystNot Ranked | Bank of China | EUR 2.97 | buy | -3.55%Downside | Reiterated | 05/02/26 | ||
| Unknown AnalystNot Ranked | CLSA | EUR 3.27 | buy | 6.09%Upside | Reiterated | 04/28/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | EUR 3.08 | buy | 0.16%Upside | Reiterated | 03/31/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 09/16/26 | EUR 4.17 | buy | 35.40%Upside | Reiterated | Morgan Stanley | ||
| Chen Chen | 08/25/26 | EUR 3.63→EUR 4.03 | hold | 30.94%Upside | Downgraded | UBS | ||
| Unknown AnalystNot Ranked | 08/25/26 | EUR 5.32 | buy | 72.86%Upside | Reiterated | BOCOM International Holdings Company | ||
| Unknown AnalystNot Ranked | 08/24/26 | EUR 5.14→EUR 7.08 | buy | 129.99%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 08/21/26 | EUR 3.34→EUR 3.79 | buy | 23.15%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 07/24/26 | EUR 3.68 | buy | 19.45%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 07/15/26 | EUR 3.52 | buy | 14.25%Upside | Reiterated | HSBC | ||
| Unknown AnalystNot Ranked | 07/14/26 | EUR 2.91 | buy | -5.41%Downside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 05/02/26 | EUR 2.97 | buy | -3.55%Downside | Reiterated | Bank of China | ||
| Unknown AnalystNot Ranked | 04/28/26 | EUR 3.27 | buy | 6.09%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 03/31/26 | EUR 3.08 | buy | 0.16%Upside | Reiterated | Bank of America Securities |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
17Q1 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 4 | 4 | 5 | 2 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 8 | 7 | 8 | 9 | 5 |
In the current month, 17Q1 has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 17Q1 average Analyst price target in the past 3 months is 4.88.
17Q1 Financial Forecast
HighEUR 0.07
ConsensusEUR 0.06
LowEUR 0.05
17Q1 Earnings Forecast
Next quarter’s earnings estimate for 17Q1 is EUR 0.06 with a range of EUR 0.05 to EUR 0.07. The previous quarter’s EPS was EUR 0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 644M
ConsensusEUR 644M
LowEUR 644M
17Q1 Sales Forecast
Next quarter’s sales forecast for 17Q1 is EUR 644.27M with a range of EUR 644.27M to EUR 644.27M. The previous quarter’s sales results were EUR 585.82M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
17Q1 Stock Forecast FAQ
What is DE:17Q1’s average 12-month price target, according to analysts?
Based on analyst ratings, Pharmaron Beijing Co., Ltd. Class H’s 12-month average price target is €4.88.
What is DE:17Q1’s upside potential, based on the analysts’ average price target?
Pharmaron Beijing Co., Ltd. Class H has 58.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pharmaron Beijing Co., Ltd. Class H a Buy, Sell or Hold?
Pharmaron Beijing Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
What is Pharmaron Beijing Co., Ltd. Class H’s share price target?
The average share price target for Pharmaron Beijing Co., Ltd. Class H is €4.88. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €7.08, and the lowest forecast is €3.79. The average share price target represents a 58.47% increase from the current price of €3.08.
What do analysts say about Pharmaron Beijing Co., Ltd. Class H?
Pharmaron Beijing Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of Pharmaron Beijing Co., Ltd. Class H?
To buy shares of DE:17Q1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
